Insulet Corporation’s recent filing unveils that its Former Officer Hollingshead James acquired Company’s shares for reported $5.04 million on May 16 ’25. In the deal valued at $323.10 per share,15,605 shares were bought.
Then, Kapples John W. sold 5,278 shares, generating $1,680,885 in total proceeds. Upon selling the shares at $318.47, the SVP and General Counsel now owns 23,180 shares.
Before that, Hopfield Jessica sold 5,235 shares. Insulet Corporation shares valued at $1,662,322 were divested by the Director at a price of $317.54 per share. As a result of the transaction, Hopfield Jessica now holds 26,917 shares, worth roughly $8.74 million.
Wolfe Research upgraded its Insulet Corporation [PODD] rating to an Outperform from a a Peer perform in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in late April from “an Outperform” to “a Peer perform”. RBC Capital Mkts began covering PODD with “an Outperform” recommendation on March 06, 2025. Bernstein started covering the stock on November 06, 2024. It rated PODD as “an Outperform”.
Price Performance Review of PODD
On Friday, Insulet Corporation [NASDAQ:PODD] saw its stock jump 0.85% to $324.75. Over the last five days, the stock has gained 4.53%. Insulet Corporation shares have risen nearly 24.39% since the year began. Nevertheless, the stocks have risen 88.51% over the past one year. While a 52-week high of $323.00 was reached on 05/16/25, a 52-week low of $170.67 was recorded on 03/10/25. SMA at 50 days reached $263.67, while 200 days put it at $250.78.
Levels Of Support And Resistance For PODD Stock
The 24-hour chart illustrates a support level at 318.35, which if violated will result in even more drops to 311.94. On the upside, there is a resistance level at 328.19. A further resistance level may holdings at 331.62. The Relative Strength Index (RSI) on the 14-day chart is 75.44, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 39.89, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 0.59%. Stochastics %K at 98.70% indicates the stock is a selling.
The most recent change occurred on May 30, 2024 when Redburn Atlantic began covering the stock and recommended ‘”a Buy”‘ rating along with a $235 price target.
